HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea Kleindienst Selected Research

peptide V

1/2013The role of vasopressin V1A receptors in cytotoxic brain edema formation following brain injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea Kleindienst Research Topics

Disease

8Brain Injuries (Brain Injury)
06/2016 - 12/2004
6Traumatic Brain Injuries (Traumatic Brain Injury)
01/2020 - 06/2005
5Neoplasms (Cancer)
01/2021 - 10/2010
5Brain Edema (Cerebral Edema)
04/2016 - 01/2008
3Glioblastoma (Glioblastoma Multiforme)
01/2021 - 11/2018
3Hypoxia (Hypoxemia)
01/2020 - 01/2013
3Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
04/2016 - 01/2012
2Inappropriate ADH Syndrome (SIADH)
07/2020 - 04/2016
2Hyponatremia
07/2020 - 04/2016
2Necrosis
01/2020 - 01/2019
2Hydrocephalus (Hydrocephaly)
01/2014 - 01/2012
2Wounds and Injuries (Trauma)
07/2013 - 12/2004
2Ischemia
01/2013 - 02/2010
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2010 - 01/2008
1Alzheimer Disease (Alzheimer's Disease)
01/2014
1Normal Pressure Hydrocephalus
01/2014
1Infections
11/2013
1Hypotension (Low Blood Pressure)
01/2013
1Infratentorial Neoplasms (Posterior Fossa Tumors)
01/2013
1Edema (Dropsy)
01/2013
1Carcinogenesis
10/2010
1Critical Illness (Critically Ill)
09/2009
1Coma (Comas)
09/2009
1Residual Neoplasm
08/2007
1Pituitary Neoplasms (Pituitary Adenoma)
08/2007

Drug/Important Bio-Agent (IBA)

5Biomarkers (Surrogate Marker)IBA
01/2020 - 08/2006
4Proteins (Proteins, Gene)FDA Link
07/2013 - 12/2004
3Vasopressins (Vasopressin)IBA
07/2020 - 01/2013
3SodiumIBA
07/2020 - 02/2010
3Nerve Growth Factors (Neurotrophins)IBA
01/2020 - 08/2006
3Oxygen (Dioxygen)IBA
01/2020 - 11/2018
2Aquaporins (Water Channels)IBA
01/2013 - 01/2008
2Tetradecanoylphorbol AcetateIBA
02/2010 - 01/2008
1Cyclic AMP (AMP, Cyclic)IBA
01/2021
1BucladesineIBA
01/2021
11- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)IBA
01/2021
1ColforsinIBA
01/2021
1TolvaptanFDA Link
07/2020
1Calcium-Binding ProteinsIBA
01/2020
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020
1Bevacizumab (Avastin)FDA Link
01/2019
1OzoneIBA
11/2018
1Osmotic DiureticsIBA
04/2016
1MineralocorticoidsIBA
04/2016
1Antidiuretic Hormone Receptor AntagonistsIBA
04/2016
1lipopolysaccharide-binding proteinIBA
11/2013
1C-Reactive ProteinIBA
11/2013
1Interleukin-6 (Interleukin 6)IBA
11/2013
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
01/2013
1peptide VIBA
01/2013
1SaltsIBA
01/2012
1Atrial Natriuretic Factor (ANF)IBA
01/2012
1CateninsIBA
10/2010
1Protein Kinase CIBA
02/2010
1PotassiumIBA
02/2010
1Aquaporin 4IBA
02/2010
1Hydrocortisone (Cortisol)FDA LinkGeneric
09/2009
1Biological ProductsIBA
08/2006

Therapy/Procedure

4Therapeutics
01/2020 - 08/2007
2Ventriculoperitoneal Shunt
01/2014 - 01/2012
1Drug Therapy (Chemotherapy)
01/2021
1Aftercare (After-Treatment)
01/2021
1Chemoradiotherapy
11/2018
1Radiotherapy
03/2013
1Artificial Respiration (Mechanical Ventilation)
09/2009
1Critical Care (Surgical Intensive Care)
09/2009
1Contraindications
08/2007